MA

Mehulkumar Ajitdan Gadhavi

Active Director Director DIN 10570156
DIN 10570156 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mehulkumar Ajitdan Gadhavi

Data last updated:

Mehulkumar Ajitdan Gadhavi is a Director at Dsrmt Health Care Private Limited (since 2024). The company operates in Healthcare.

DIN 10570156
Primary Designation Director
Industry Healthcare
First Appointment 29 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dsrmt Health Care Private Limited U86100GJ2024PTC150096
Director29 Mar 20242024Active

Directorship timeline

Open interactive timeline →
Dsrmt Health Care Private Limited
Premium access

Shareholding and investment profile for Mehulkumar Ajitdan Gadhavi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mehulkumar Ajitdan Gadhavi

Mehulkumar Ajitdan Gadhavi currently holds 1 directorship: Dsrmt Health Care Private Limited (Director, since 29 Mar 2024).

Mehulkumar Ajitdan Gadhavi was first appointed on 29 Mar 2024 as Director at Dsrmt Health Care Private Limited.

The current boards of Mehulkumar Ajitdan Gadhavi's companies include Jyotsanaben Dilipbhai Barad (Dsrmt Health Care Private Limited), Sardarsinh Narendrasinh Dabhi (Dsrmt Health Care Private Limited), Tapan Rajendrabhai Upadhyay (Dsrmt Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available